Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis

Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81:112–7. https://doi.org/10.1016/j.jbspin.2013.09.003.

Article  PubMed  Google Scholar 

Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur A-M, Suarez-Almazor ME, Woo P. International League of Associations for Rheumatology, International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.

PubMed  Google Scholar 

Eng SWM, Duong TT, Rosenberg AM, Morris Q, Yeung RSM. REACCH OUT and BBOP Research Consortia, the biologic basis of clinical heterogeneity in juvenile idiopathic arthritis. Arthritis Rheumatol. 2014;66:3463–75. https://doi.org/10.1002/art.38875.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rezaei E, Hogan D, Trost B, Kusalik AJ, Boire G, Cabral DA, Campillo S, Chédeville G, Chetaille A-L, Dancey P, Duffy C, Duffy KW, Eng SWM, Gordon J, Guzman J, Houghton K, Huber AM, Jurencak R, Lang B, Laxer RM, Morishita K, Oen KG, Petty RE, Ramsey SE, Scherer SW, Scuccimarri R, Spiegel L, Stringer E, Taylor-Gjevre RM, Tse SML, Tucker LB, Turvey SE, Tupper S, Wintle RF, Yeung RSM, Rosenberg AM. BBOP Study Group, associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categories. Rheumatology (Oxford). 2020;59:1066–75. https://doi.org/10.1093/rheumatology/kez382.

Article  CAS  PubMed  Google Scholar 

Martini A, Ravelli A, Avcin T, Beresford MW, Burgos-Vargas R, Cuttica R, Ilowite NT, Khubchandani R, Laxer RM, Lovell DJ, Petty RE, Wallace CA, Wulffraat NM, Pistorio A, Ruperto N. Pediatric Rheumatology International Trials Organization (PRINTO), toward new classification criteria for juvenile idiopathic arthritis: first steps. Pediatr Rheumatol Int Trials Organ Int Consensus J Rheumatol. 2019;46:190–7. https://doi.org/10.3899/jrheum.180168.

Article  Google Scholar 

Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2018;77:819–28. https://doi.org/10.1136/annrheumdis-2018-213030.

Article  PubMed  Google Scholar 

Giancane G, Muratore V, Marzetti V, Quilis N, Benavente BS, Bagnasco F, Alongi A, Civino A, Quartulli L, Consolaro A, Ravelli A. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era. Arthritis Res Ther. 2019;21:168. https://doi.org/10.1186/s13075-019-1950-7.

Article  PubMed  PubMed Central  Google Scholar 

Shoop-Worrall SJW, Kearsley-Fleet L, Thomson W, Verstappen SMM, Hyrich KL. How common is remission in juvenile idiopathic arthritis: a systematic review. Semin Arthritis Rheum. 2017;47:331–7. https://doi.org/10.1016/j.semarthrit.2017.05.007.

Article  PubMed  PubMed Central  Google Scholar 

Wallace CA, Ruperto N, Giannini E. Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group, preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31:2290–4.

PubMed  Google Scholar 

Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C, Pederzoli S, Davì S, Martini A, Ravelli A. Paediatric Rheumatology International Trials Organization, Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Arthritis Rheum. 2012;64:2366–74. https://doi.org/10.1002/art.34373.

Article  PubMed  Google Scholar 

Consolaro A, Negro G, Chiara Gallo M, Bracciolini G, Ferrari C, Schiappapietra B, Pistorio A, Bovis F, Ruperto N, Martini A, Ravelli A. Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. Arthritis Care Res (Hoboken). 2014;66:1703–9. https://doi.org/10.1002/acr.22393.

Article  PubMed  Google Scholar 

Ravelli A, Martini A. Remission in juvenile idiopathic arthritis. Clin Exp Rheumatol 24 (2006) S105–110.

Shenoi S, Wallace CA. Remission in juvenile idiopathic arthritis: current facts. Curr Rheumatol Rep. 2010;12:80–6. https://doi.org/10.1007/s11926-010-0085-2.

Article  PubMed  Google Scholar 

Rypdal V, Arnstad ED, Aalto K, Berntson L, Ekelund M, Fasth A, Glerup M, Herlin T, Nielsen S, Peltoniemi S, Zak M, Rygg M, Rypdal M, Nordal E. Nordic Study Group of Pediatric Rheumatology (NoSPeR), Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the nordic cohort study. Arthritis Res Ther. 2018;20:91. https://doi.org/10.1186/s13075-018-1571-6.

Article  PubMed  PubMed Central  Google Scholar 

Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, Huber AM, Oen K, Gerhold K, Feldman BM, Scuccimarri R, Houghton K, Chédeville G, Morishita K, Lang B, Dancey P, Rosenberg AM, Barsalou J, Bruns A, Watanabe Duffy K, Benseler S, Duffy CM, Tucker LB. ReACCh-Out investigators, Predicting which children with juvenile idiopathic arthritis will not attain early remission with Conventional Treatment: results from the ReACCh-Out cohort. J Rheumatol. 2019;46:628–35. https://doi.org/10.3899/jrheum.180456.

Article  PubMed  Google Scholar 

Spreafico R, Rossetti M, van Loosdregt J, Wallace CA, Massa M, Magni-Manzoni S, Gattorno M, Martini A, Lovell DJ, Albani S. A circulating reservoir of pathogenic-like CD4 + T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment. Ann Rheum Dis. 2016;75:459–65. https://doi.org/10.1136/annrheumdis-2014-206226.

Article  CAS  PubMed  Google Scholar 

Rossetti M, Spreafico R, Consolaro A, Leong JY, Chua C, Massa M, Saidin S, Magni-Manzoni S, Arkachaisri T, Wallace CA, Gattorno M, Martini A, Lovell DJ, Albani S. TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis. Ann Rheum Dis. 2017;76:435–41. https://doi.org/10.1136/annrheumdis-2015-208992.

Article  CAS  PubMed  Google Scholar 

van Dijkhuizen EHP, Del Chierico F, Malattia C, Russo A, Pires Marafon D, Ter Haar NM, Magni-Manzoni S, Vastert SJ, Dallapiccola B, Prakken B, Martini A, De Benedetti F, Putignani L, Model Driven Paediatric European Digital Repository Consortium. Microbiome Analytics of the gut microbiota in patients with juvenile idiopathic arthritis: a longitudinal Observational Cohort Study. Arthritis Rheumatol. 2019;71:1000–10. https://doi.org/10.1002/art.40827.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orczyk K, Smolewska E. The potential importance of MicroRNAs as Novel indicators how to manage patients with juvenile idiopathic arthritis more effectively. J Immunol Res. 2021;2021:9473508. https://doi.org/10.1155/2021/9473508.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosina S, Natoli V, Santaniello S, Trincianti C, Consolaro A, Ravelli A. Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis. Expert Rev Clin Immunol. 2021;17:853–70. https://doi.org/10.1080/1744666X.2021.1945441.

Article  CAS  PubMed  Google Scholar 

Fischer J, Dirks J, Haase G, Holl-Wieden A, Hofmann C, Girschick H, Morbach H. IL-21 + CD4 + T helper cells co-expressing IFN-γ and TNF-α accumulate in the joints of antinuclear antibody positive patients with juvenile idiopathic arthritis. Clin Immunol. 2020;217:108484. https://doi.org/10.1016/j.clim.2020.108484.

Article  CAS  PubMed  Google Scholar 

Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3 + regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490–500. https://doi.org/10.1038/nri2785.

Article  CAS  PubMed  Google Scholar 

Shan J, Jin H, Xu Y, Cell Metabolism T. A New Perspective on Th17/Treg Cell Imbalance in systemic Lupus Erythematosus. Front Immunol. 2020;11:1027. https://doi.org/10.3389/fimmu.2020.01027.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang Q, Yang G, Liu Q, Wang S, Cui D. Function and Role of Regulatory T Cells in rheumatoid arthritis. Front Immunol. 2021;12:626193. https://doi.org/10.3389/fimmu.2021.626193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng M, Guo H, Zhang C, Wang Y, Liang Z, Zhao X, Qin Y, Wu Y, Liu G, Gao C, Luo J. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis. Int Immunopharmacol. 2019;77:105912. https://doi.org/10.1016/j.intimp.2019.105912.

Article  CAS  PubMed  Google Scholar 

Frantz C, Auffray C, Avouac J, Allanore Y. Regulatory T cells in systemic sclerosis. Front Immunol. 2018;9:2356. https://doi.org/10.3389/fimmu.2018.02356.

Article  CAS  PubMed  PubMed Central 

Comments (0)

No login
gif